| 000 | 01498 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515003819.0 | ||
| 264 | 0 | _c20060110 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a1351-5101 | ||
| 024 | 7 |
_a10.1111/j.1468-1331.2005.01084.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeder, C | |
| 245 | 0 | 0 |
_aClinical and immune responses correlate in glatiramer acetate therapy of multiple sclerosis. _h[electronic resource] |
| 260 |
_bEuropean journal of neurology _cNov 2005 |
||
| 300 |
_a869-78 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiomarkers _xanalysis |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 | _aGlatiramer Acetate |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmune Tolerance |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
| 650 | 0 | 4 |
_aPeptides _xtherapeutic use |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTh2 Cells |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBaltariu, G M | |
| 700 | 1 | _aWyler, K A | |
| 700 | 1 | _aGober, H-J | |
| 700 | 1 | _aLienert, C | |
| 700 | 1 | _aSchluep, M | |
| 700 | 1 | _aRadü, E W | |
| 700 | 1 | _aDe Libero, G | |
| 700 | 1 | _aKappos, L | |
| 700 | 1 | _aDuda, P W | |
| 773 | 0 |
_tEuropean journal of neurology _gvol. 12 _gno. 11 _gp. 869-78 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1468-1331.2005.01084.x _zAvailable from publisher's website |
| 999 |
_c15869746 _d15869746 |
||